Celcuity Other Current Liability (Quarterly) Analysis

Celcuity, Inc. (CELC)

106.11 +1.60 (+1.53%) USD | NASDAQ | Jan 13, 14:59

View Other Current Liability (Quarterly) for CELC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Liability (Quarterly) Benchmarks

Start Trial

Olema Pharmaceuticals, Inc.	--
Replimune Group, Inc.	Upgrade
Arrowhead Pharmaceuticals, Inc.	Upgrade
Cidara Therapeutics, Inc.	--
Cogent Biosciences, Inc.	Upgrade